VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $412 | -90.7% | 73 | -89.2% | 0.00% | – |
| Q2 2023 | $4,435 | +483.6% | 673 | +500.9% | 0.00% | – |
| Q1 2023 | $760 | -81.3% | 112 | -79.6% | 0.00% | -100.0% |
| Q4 2022 | $4,065 | -32.2% | 550 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | -60.0% | 646 | -52.6% | 0.00% | -50.0% |
| Q2 2022 | $15,000 | +87.5% | 1,364 | +101.5% | 0.00% | +100.0% |
| Q1 2022 | $8,000 | -20.0% | 677 | +4.8% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | -9.1% | 646 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $11,000 | -21.4% | 646 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | +40.0% | 646 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $10,000 | +25.0% | 646 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +33.3% | 646 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | 0.0% | 646 | +17.5% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | 0.0% | 550 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |